国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Conus caracteristicus Conotoxin Ca11a CSB-YP515026DVW
CSB-EP515026DVW
CSB-BP515026DVW
CSB-MP515026DVW
CSB-EP515026DVW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca GTPase Era, mitochondrial (ERAL1) CSB-YP515027AYX
CSB-EP515027AYX
CSB-BP515027AYX
CSB-MP515027AYX
CSB-EP515027AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ailuropoda melanoleuca Riboflavin transporter 2 (RFT2), partial CSB-YP515028AYX
CSB-EP515028AYX
CSB-BP515028AYX
CSB-MP515028AYX
CSB-EP515028AYX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Beta vulgaris subsp. maritima CASP-like protein Ni6 (Ni6), partial CSB-YP515029BSR1
CSB-EP515029BSR1
CSB-BP515029BSR1
CSB-MP515029BSR1
CSB-EP515029BSR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O150:H5 Putative aminoacrylate hydrolase RutD (rutD) CSB-YP515030EOC
CSB-EP515030EOC
CSB-BP515030EOC
CSB-MP515030EOC
CSB-EP515030EOC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rothia mucilaginosa L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase (mshC) CSB-YP515031ROP
CSB-EP515031ROP
CSB-BP515031ROP
CSB-MP515031ROP
CSB-EP515031ROP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serotype 1/2a Listeriolysin O (hly), partial CSB-YP515032LPU
CSB-EP515032LPU
CSB-BP515032LPU
CSB-MP515032LPU
CSB-EP515032LPU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kribbella flavida D-inositol 3-phosphate glycosyltransferase (mshA) CSB-YP515033KBS
CSB-EP515033KBS
CSB-BP515033KBS
CSB-MP515033KBS
CSB-EP515033KBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium dentium Prokaryotic ubiquitin-like protein Pup (pup) CSB-YP515034BSZ
CSB-EP515034BSZ
CSB-BP515034BSZ
CSB-MP515034BSZ
CSB-EP515034BSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acidaminococcus fermentans Protein translocase subunit SecF (secF), partial CSB-YP515035AWA1
CSB-EP515035AWA1
CSB-BP515035AWA1
CSB-MP515035AWA1
CSB-EP515035AWA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloterrigena turkmenica HGPRTase-like protein 3 (Htur_2490) CSB-YP515036HUD
CSB-EP515036HUD
CSB-BP515036HUD
CSB-MP515036HUD
CSB-EP515036HUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloterrigena turkmenica Glucose 1-dehydrogenase 2 (gdh2) CSB-YP515037HUD
CSB-EP515037HUD
CSB-BP515037HUD
CSB-MP515037HUD
CSB-EP515037HUD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geodermatophilus obscurus 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (mshB) CSB-YP515038GFT
CSB-EP515038GFT
CSB-BP515038GFT
CSB-MP515038GFT
CSB-EP515038GFT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erwinia pyrifoliae Cell division inhibitor SulA (sulA) CSB-YP515039EMY
CSB-EP515039EMY
CSB-BP515039EMY
CSB-MP515039EMY
CSB-EP515039EMY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter rodentium Probable propionate kinase (pduW) CSB-YP515040DTP
CSB-EP515040DTP
CSB-BP515040DTP
CSB-MP515040DTP
CSB-EP515040DTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heloderma suspectum cinctum Helofensin-2 CSB-YP515041HVK
CSB-EP515041HVK
CSB-BP515041HVK
CSB-MP515041HVK
CSB-EP515041HVK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Medicago truncatula Flotillin-like protein 4 (FLOT4) CSB-YP515042MQP
CSB-EP515042MQP
CSB-BP515042MQP
CSB-MP515042MQP
CSB-EP515042MQP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cal14a CSB-YP515043DVU
CSB-EP515043DVU
CSB-BP515043DVU
CSB-MP515043DVU
CSB-EP515043DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus californicus Conotoxin Cal1.1b CSB-YP515044DVU
CSB-EP515044DVU
CSB-BP515044DVU
CSB-MP515044DVU
CSB-EP515044DVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haplopelma hainanum Mu-theraphotoxin-Hhn2a CSB-YP515045HUK
CSB-EP515045HUK
CSB-BP515045HUK
CSB-MP515045HUK
CSB-EP515045HUK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>